Cetera Investment Advisers’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Cetera Investment Advisers's BBH Position: Q1 2026 in Review
Cetera Investment Advisers reduced its VanEck Biotech ETF (BBH) stake by 2.3% in Q1 2026, selling an estimated $9.44K and leaving 2,055 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.
Cetera Investment Advisers first reported a position in BBH in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.28M in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Cetera Investment Advisers held 2,055 shares of VanEck Biotech ETF worth $386K as of Q1 2026.
- Cetera Investment Advisers sold 49 VanEck Biotech ETF shares in Q1 2026, an estimated $9.44K.
- VanEck Biotech ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3751 holding.
- Cetera Investment Advisers first reported a position in VanEck Biotech ETF in Q4 2020 and has held it in 18 quarters since.
- Cetera Investment Advisers's VanEck Biotech ETF position peaked at $1.28M in Q3 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.